3D Tissue Models

Biology: Amgen

Total Score People Score Events Score
19 18 15
Date Event Presentation Speakers
March 19, 2014 3rd Neurological Biomarkers Executive Panel: Companion Diagnostics & Partnering Strategies Scott D Patterson
January 31, 2013 11th Cytokines and Inflammation Modeling the Distinct Roles for IL-23 and IL-17 in Inflammatory Bowel Disease Using mdr1a-/- Mice Jennifer Towne
August 5, 2009 New Frontiers in Cancer Drug Development AMG 386, an Anti-Angiogenic Agent Targeting the Angiopoietin-Tie2 Pathway Jon Oliner
Biomarker Clinical Utility: How Can Qualification of a Biomarker's Clinical Utility Be Determined? Prospective or Retrospective or a Combination? Scott D Patterson
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Ligands of Orphan GPCRs Identified from Inducible Expression of the Receptors and Cell-based Reporter Screen Paul Lee
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety Translating Metabolomic Data into Mechanistic Understanding and Action: A Case Study Jeffrey W. Lawrence
June 9, 2009 RNAi for Target Identification and Validation A Framework for the Analysis of RNAi Phenotypes as Quantitative Traits Kim Quon
February 11, 2009 4th annual Bioanalysis in Clinical Research Regulatory requirements for incurred sample analysis Binodh DeSilva
February 9, 2009 Immunogenicity for Biologics 2009 Methodology for immunogenicity assessment Steve Swanson
Incurred sample reanalysis – Amgen’s experiences Mark Ma
January 26, 2009 7th Annual Partnering with Central Labs B2 : Archival Surgical Pathology Specimens: A New Exercise in Clinical Trials Carol W Johnson
Risk Assessment : Current and Future Metrics Champion Consortium Metrics Initiatives Sue Hwang
PANEL DISCUSSION : Comparing Approaches: Preferred Providers vs Competitive Bidding, What is your Best Choice? Roberto Vaccaro
Track A : Overview of Metrics: Definition Refinement & Update from the Central Lab MCC Initiative Sue Hwang
October 22, 2008 Targeting Diabetes With Novel Therapeutics GPR40 Agonists for the Treatment of Type 2 Diabetes Daniel Lin
October 21, 2008 RNAi for Screening Chairperson’s Remarks Paul D. Kassner
Beneficial Use of siRNA Off-Target Effects for Assay Development, Screening Quality Control, and Hit-Selection Paul D. Kassner
Strategies for Effective RNAi Screens Paul D. Kassner
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic In Vivo Imaging in Early Drug Development Jeffrey Evelhoch
February 17, 2008 GRC - Peptides, Chemistry & Biology Of Design and Synthesis of Calcitonin-Gene Related Peptide (CGRP) Antagonists Jerry "Ryan" Holder
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Pre-Conference Workshops; Biomarker Assay Development and Validation: Part I Tutorial FIT-FOR-PURPOSE BIOMARKER ASSAY DEVELOPMENT AND VALIDATION (08:00-12:00) Jean W Lee
August 4, 2007 Glucose Transporter Biology Dynamic Cycling of O-GlcNAc: Roles in Insulin- Resistance and in Glucose Toxicity Roger A. Hart
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.